1-20 of 75 results for subject:Screening
Librarians' tools
- Search time
- 0.254 seconds
- Solr query time
- 0.008 seconds
- Search query
- subject:Screening
- We searched for
- subject_t:Screening OR subject_ses:92923
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask Her Majesty's Government what measures are in place to test patients treated with macrolide therapy for non-tuberculous mycobacteria; and how many of these tests have been undertaken in England.
To ask Her Majesty's Government what measures are in place to test patients treated with macrolide therapy for non-tuberculous mycobacteria; and how many of these tests have been undertaken in England.
No formal assessment has been made. Patients with non-tuberculous mycobacteria will continue to be managed in primary and secondary care settings and treated with the current available treatments known as ‘Guideline Based Therapy’ as recommended by the British Thoracic Society.
The British Thoracic Society guideline for the use of longterm macrolides in adults with respiratory disease suggests that patients who are able to expectorate should be considered for testing for non-tuberculous mycobacteria prior to starting long-term macrolide therapy. A copy of the guideline is attached. NHS England and NHS Improvement do not hold data on the number of tests undertaken.
To ask Her Majesty's Government whether COVID-19 tests will remain (1) free, and (2) accessible, for (a) all immunocompromised people, (b) their households, and (c) close contacts, from 1 April, for those who are either (i) symptomatic, or (ii) asymptomatic.
To ask Her Majesty's Government whether COVID-19 tests will remain (1) free, and (2) accessible, for (a) all immunocompromised people, (b) their households, and (c) close contacts, from 1 April, for those who are either (i) symptomatic, or (ii) asymptomatic.
From 1 April, free access to asymptomatic and symptomatic tests for the public in England will end. The Government will continue to provide free symptomatic testing for patients in hospital, for whom a test is required for clinical management or to support treatment pathways and those eligible for COVID-19 treatments due to their higher risk of getting seriously ill from COVID-19.
Patients in this higher risk cohort will be contacted directly and sent lateral flow device tests for symptomatic testing and guidance on how to reorder tests. Asymptomatic lateral flow device testing will continue in some high-risk settings where infection can spread rapidly while prevalence is high.
To ask Her Majesty's Government what plans they have to encourage breast screening units to work with their communities to (1) design, and (2) deliver, an equitable recovery of the programme.
To ask Her Majesty's Government what plans they have to encourage breast screening units to work with their communities to (1) design, and (2) deliver, an equitable recovery of the programme.
Breast cancer screening providers are being encouraged to work with Cancer Alliances, Primary Care Networks and National Health Service regional teams to promote the uptake of breast screening services and ensure local populations can access services. NHS England and NHS Improvement have allocated £22 million for replacement mobile breast screening units and £50 million to increase capacity and activity in England.
To ask Her Majesty's Government what plans they have to ensure that (1) communication, and (2) information, around breast screening is properly tailored to reach different (a) communities, and (b) age groups.
To ask Her Majesty's Government what plans they have to ensure that (1) communication, and (2) information, around breast screening is properly tailored to reach different (a) communities, and (b) age groups.
Breast screening information leaflets have been developed with contributions from women representing a wide range of backgrounds and ages. These leaflets are available both in hard copy and online in the 10 most requested languages. An easy read version of the guide to breast screening has also been developed. In addition, an animation about screening programmes for women, featuring breast screening and guidance for screening services on reducing inequalities in the programme is available.
A separate leaflet is provided for women aged 71 years old and over which explains that although they no longer receive routine invitations, breast screening can be requested every three years.
My Lords, as GPs are having to work in vaccination centres, would it be possible for people who think they have or may have cancer—breast cancer or other cancers—to go straight to secondary care for investigations? GPs cannot do everything at the same time. Does the Minister agree with me that it is important to have a speedy diagnosis for cancer?
My Lords, as GPs are having to work in vaccination centres, would it be possible for people who think they have or may have cancer—breast cancer or other cancers—to go straight to secondary care for investigations? GPs cannot do everything at the same time. Does the Minister agree with me that it is important to have a speedy diagnosis for cancer?
I think all noble Lords would agree with the noble Baroness that it is important we have speedy diagnosis. On the specific question, I will check and get back to her.
My Lords, I thank the Minister for repeating this very important Statement. Many people are concerned about taking the booster because they do not know what the result will be of mixing vaccines such as Pfizer and AstraZeneca. Nobody seems able to give advice. It is very worrying. GP surgeries...
My Lords, I thank the Minister for repeating this very important Statement. Many people are concerned about taking the booster because they do not know what the result will be of mixing vaccines such as Pfizer and AstraZeneca. Nobody seems able to give advice. It is very worrying. GP surgeries...
My Lords, it is very difficult to find out why many people are hesitant about having a booster jab having had two vaccinations. Does the Minister think that, if something went wrong and left a person seriously disabled from the vaccine, but if they knew they would have adequate compensation,...
My Lords, it is very difficult to find out why many people are hesitant about having a booster jab having had two vaccinations. Does the Minister think that, if something went wrong and left a person seriously disabled from the vaccine, but if they knew they would have adequate compensation,...
To ask Her Majesty's Government what guidance they have issued on whether people should return to work after having had COVID-19 but without having taken a PCR test.
To ask Her Majesty's Government what guidance they have issued on whether people should return to work after having had COVID-19 but without having taken a PCR test.
We have issued online guidance on 11 October which states that individuals who have COVID-19 symptoms should stay at home and a polymerase chain reaction (PCR) test. Anyone subsequently notified by NHS Test and Trace or local authority contact tracer that they have tested positive is legally required to self-isolate. Employees should notify their employer in such circumstances.
An individual can return to work, after the end of their self-isolation period if their symptoms have gone or if the only symptoms they have are a cough or anosmia, which can last for several weeks. There is no requirement to return a negative PCR test in order to end self-isolation. Individuals who still have a high temperature or are otherwise unwell should stay at home and seek medical advice.
To ask Her Majesty's Government what steps they are taking to expand flu testing, including through (1) at-home testing, and (2) testing in the community, in 2021–22.
To ask Her Majesty's Government what steps they are taking to expand flu testing, including through (1) at-home testing, and (2) testing in the community, in 2021–22.
The diagnosis of influenza is generally made using clinical symptoms in primary care settings and can only be confirmed by laboratory testing. Rapid testing should be undertaken in all people with complicated influenza which often takes place in hospital. The Department is exploring potential options to expanding winter virus testing via home or community testing.
To ask Her Majesty's Government what assessment they have made of the efficacy of the current pathway to test and treat influenza.
To ask Her Majesty's Government what assessment they have made of the efficacy of the current pathway to test and treat influenza.
We have not made a specific assessment. However, the diagnosis of influenza is generally made using clinical symptoms in primary care settings then confirmed by laboratory testing. Rapid testing for complicated influenza often takes place in hospitals. The treatment of influenza can involve antiviral medication and/or hospital admission. As a preventative measure, priority groups most at risk and frontline health and adult social care workers are eligible for a free influenza vaccine to protect them and prevent onward transmission to vulnerable members of the community.
My Lords, the four-tier regulations have been overtaken by the England-wide lockdown. Suddenly, from being in tier 2, we in North Yorkshire found ourselves in lockdown, with so many difficulties and insecurities to cope with. With the devastating news yesterday that 1,000 people died in 24 hours, people are realising...
My Lords, the four-tier regulations have been overtaken by the England-wide lockdown. Suddenly, from being in tier 2, we in North Yorkshire found ourselves in lockdown, with so many difficulties and insecurities to cope with. With the devastating news yesterday that 1,000 people died in 24 hours, people are realising...
My Lords, what does the Minister think about trained sniffer dogs to detect Covid-19? Does he know that the
London School of Hygiene & Tropical Medicine is one of several groups that have assessed the accuracy of using sniffer dogs?
My Lords, what does the Minister think about trained sniffer dogs to detect Covid-19? Does he know that the
London School of Hygiene & Tropical Medicine is one of several groups that have assessed the accuracy of using sniffer dogs?
My Lords, I take my hat off to the London School of Hygiene & Tropical Medicine, which runs an extremely exciting trial. In fact, the Secretary of State is visiting this very afternoon in order to get an update on that trial. Dogs can be used as a way of screening crowds in such places as airports and high-density venues. The validation of that method has not been proven yet, but I am personally extremely hopeful and remain grateful to those involved in the pilot.
To ask Her Majesty's Government what plans they have in place to ensure a supply of medicine and COVID-19 test equipment in the event of any shortage of such supplies.
To ask Her Majesty's Government what plans they have in place to ensure a supply of medicine and COVID-19 test equipment in the event of any shortage of such supplies.
As part of our concerted national efforts to respond to the COVID-19 outbreak, we are doing everything we can to ensure patients continue to have access to COVID-19 test equipment and medicines in all scenarios. This includes holding stockpiles of a variety of medicines currently and potentially used in treating patients with COVID-19, to help ensure there is uninterrupted supply over the coming months.
The Department has well-established procedures to deal with shortages and works closely with industry, the National Health Service and others in the supply chain to address supply disruption events that arise, regardless of the cause.
My Lords, how is new technology being brought to the front line to deliver critical care and services across the country? Is the Minister aware of the desperate shortage of doctors and nurses working on the front line of infections, and that they are exhausted? What can be done to...
My Lords, how is new technology being brought to the front line to deliver critical care and services across the country? Is the Minister aware of the desperate shortage of doctors and nurses working on the front line of infections, and that they are exhausted? What can be done to...
To ask Her Majesty's Government whether agency nurses working in hospitals, nursing homes and care homes are being tested for COVID-19.
To ask Her Majesty's Government whether agency nurses working in hospitals, nursing homes and care homes are being tested for COVID-19.
All National Health Service and social care staff, including nurses, can apply for a test if they are experiencing symptoms using digital portal. The employer referral portal allows employers to refer essential workers who are self-isolating either because they or member(s) of their household have COVID-19 symptoms, for testing.
Asymptomatic care home staff are now eligible for testing through the ‘whole home’ testing portal.
My Lords, I thank the noble Baroness, Lady Wheeler, for securing this debate. That so many people are speaking shows how important this extraordinary virus is.
I have had many disabled people contact me. One was the wife of a man who has multiple neurological problems. His conditions, because he has...
My Lords, I thank the noble Baroness, Lady Wheeler, for securing this debate. That so many people are speaking shows how important this extraordinary virus is.
I have had many disabled people contact me. One was the wife of a man who has multiple neurological problems. His conditions, because he has...
To ask Her Majesty's Government what steps they are taking to test people suspected of having COVID-19 in line with World Health Organisation advice including (1) the elderly, and (2) disabled people living on their own.
To ask Her Majesty's Government what steps they are taking to test people suspected of having COVID-19 in line with World Health Organisation advice including (1) the elderly, and (2) disabled people living on their own.
The Government’s response is built around protecting those who are most vulnerable in our society. Testing is a crucial part of the United Kingdom’s response to the COVID-19 pandemic and we are working on multiple fronts to deliver additional testing capacity into the system.
As we have moved from ‘contain’ and into the ‘delay’ phase of COVID-19, Public Health England, together with NHS England and the Department, has agreed we will need to prioritise testing for those most at risk of severe illness from the virus. Our aim is to save lives, protect the most vulnerable, and relieve pressure on the National Health Service.
As a result, tests will primarily be given to:
- all patients in critical care for pneumonia, acute respiratory distress syndrome (ARDS) or flu like illness; and
- all other patients requiring admission to hospital for pneumonia, ARDS or flu-like illness
The Government is looking at wider testing for those in less critical states. As announced on 27 March, the Government is working with industry, philanthropy and universities to significantly scale up testing.
My Lords, is it true that the prisoners who are ill abroad are not being tested? Surely all of them should be tested and treated.
My Lords, is it true that the prisoners who are ill abroad are not being tested? Surely all of them should be tested and treated.
My Lords, the Statement puts importance on technology. Will the Government speed up NICE in its assessments of technology? I hear that it is taking too long.
My Lords, the Statement puts importance on technology. Will the Government speed up NICE in its assessments of technology? I hear that it is taking too long.
To ask Her Majesty's Government when they intend to make funding available to implement the UK National Screening Committee's recommendation of 2017 to undertake a practical evaluation of new born screening for Severe Combined Immunodeficiency Disease in the NHS.
To ask Her Majesty's Government when they intend to make funding available to implement the UK National Screening Committee's recommendation of 2017 to undertake a practical evaluation of new born screening for Severe Combined Immunodeficiency Disease in the NHS.
The UK National Screening Committee completed a public consultation on 4 November 2017 on whether a proposal for a practical evaluation of Severe Combined Immunodeficiency (SCID) was supported. It has since recommended a practical evaluation of SCID screening to be undertaken in the National Health Service. This evaluation will be considered as part of the 2019/20 funding decisions.